.jpg)
This is the challenge and opportunity, to relinquish control enough to be "generous", inviting people in to understand what relevance and value is to them, and remaining honest to this. Anytime you engage with your audience to in a value-driven way, even in the absence of branding, this is more meaningful. In fact, delivering content in a commercial-neutral way may be even more meaningful. It becomes engagement, not advertising. For pharma, this is still intimidating if not inviting risk. If you execute on this consistently your customer will associate the quality of content with your brand and your company. Social media has proven this out for us. Today, there is no shortage of pharma and health company presence in social media. Yet, ad spending on these channels is at the bottom of the investment priority. What tops the list is creating content and applications that actually help audiences, either by giving them a place to find support or information, or enabling them to make more informed decisions. It takes longer to show ROI, but the ROI promises to be greater, with more longevity. In the end, the mantra, "if you build it they will come", rings truer than ever, it just has to be welcomed.
Right now, Convergence via TVs is in the "make it easier" stage - such as with Netflix. I am watching out for the proliferation of what the now nearly-dead, WebTV promised - true engagement and relationship.
No comments:
Post a Comment